- $410
- BioPorto
- 丹麦
- HYB 133-01
- 2025年07月07日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20ºC
- 保质期：
1年
- 库存：
30
- 供应商：
上海泽叶生物科技有限公司
- 抗体英文名：
Anti-Factor IX (human, Christmas factor)
- 规格：
200ug
Anti-Factor IX (human, Christmas factor)
Bioporto是一家体外诊断公司，专业为临床和科研提供一系列诊断试剂盒和抗体。其领先的产品组合包括了用于急性肾功能损伤诊断用的NGAL以及其它疾病检测用抗体。官方网站：www.bioporto.com
- Cat. No.
- HYB 133-01
- Product name
- Anti-Factor IX (human, Christmas factor)
- Description
-
Mouse monoclonal antibody
- Specificity
-
HYB 133-01 is specific for native human factor IX.
- Immunogen
-
Factor IX isolated from human plasma
- Application
- ELISA, WB
- Species reactivity (positive)
- Human
- Species reactivity (negative)
- Not determined
- Subclass
-
IgG1/k
- Gene ID
- 2158
- Clone number
- 1C2
- Epitope
-
Epitope specificity differs from that of HYB 133-09 as determined by inhibition ELISA.
- Content
-
Available in 200 µL and 1 mL size.1 mg/mL +/- 15%. See Certificate of Analysis for details.
- Purification
- Protein-A purified
- Form
- Liquid
- Solvent
- 0.01 M phosphate buffer, pH 7.4, containing 0.5 M NaCl and 15 mM sodium azide
- Storage
- 4-8ºC without exposure to light. No precautions necessary during handling.
- Target
-
Coagulation factor IX is a single chain polypeptide with a molecular mass of 57 kDa. Normal concentrations of factor IX in human plasma is app. 3 µg/ml. Factor IX deficiency and lack of coagulation activity is seen in patients suffering from the innate X-chromosome linked disorder, haemophilia B.
- Application 1
-
ELISA
HYB 133-01 reacts strongly with native factor IX. Strong reaction is seen in ELISA with native factor IX directly coated onto the microtiter well, and also when tested in sandwich ELISA in combination with a polyclonal antibody against factor IX. - Application 2
-
WB
In Western blotting after SDS-PAGE, HYB 133-01 reacts with factor IX in non-reduced form only.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Factor IX Gene Therapy for Hemophilia
Using gene therapy to produce systemic levels of human factor IX for the treatment of hemophilia B has been clinically evaluated using viral-based vectors. The efficacy of this approach has been limited because of immune responses
Tachyplesin and Anti-Lipopolysaccharide Factor
Hemolymph of invertebrate animals contains many molecules involved in unique and effective innate defense systems against invading microbes. Their defense systems are activated by the recognition of common epitopes on pathogens
Anti-factor Xa (Anti-Xa) Assay
The anti-factor Xa (anti-Xa) assay is a functional assay that facilitates the measurement of antithrombin (AT)-catalyzed inhibition of factor Xa by unfractionated heparin (UFH) and direct inhibition of factor Xa by low-molecular-weight
技术资料暂无技术资料 索取技术资料
